Category Archives: Genetics

Professor Ross Houston to join BMK Genetics in 2022 – The Fish Site

Professor Houston is well known in the aquaculture genetics and animal breeding communities. He began his career with a PhD in pig genetics at the University of Aberdeen in 2004 before moving into salmon genetics in a postdoc position at Roslin. Ever since, he has built an international reputation in the field, including discovering a major QTL associated with resistance to Infectious Pancreatic Necrosis in 2008, which remains an exemplar of using genetics to help control disease and improve health.

Houston leads several high-profile international aquaculture research projects focussing on application of genomics and genome editing technologies to improve disease resistance. He has authored and co-authored over 100 peer-reviewed publications and has received several awards for his contributions to the scientific community.

In the role of Director of Innovation, he will lead BGs strategic development of innovation and R&D to support business growth and secure the companys competitive advantages. He will also develop and lead collaborative projects both internally and externally, including harnessing synergies on innovation across the field of genetics, health, and nutrition within the Benchmark Group as a member of Benchmarks cross-divisional Innovation Board.

The new role will also involve product development for the Benchmark Genetics in-house breeding programmes in salmon, shrimp, and tilapia. Finally, Ross will assist in expanding the portfolio of external clients for the applied genetics consultancy services, of which Benchmark Genetics has been in the forefront for more than three decades.

Dr Morten Rye, Director of Genetics in Benchmark, says: Getting Ross Houston on board significantly strengthens our genetics R&D capacities and is also a great acknowledgement to the reputation of our organisation. Genetics technologies are rapidly advancing, and I am convinced that having Ross to lead our strategic development of innovation and R&D will place Benchmark in the forefront of this progress.

Ross Houston is excited about the new position and adds: I have been collaborating with Benchmark scientists for several years, and I am impressed about how the genetics business area has developed during this time. Im very motivated by translating the latest scientific developments into commercial practice, to benefit the organisation as well as enhancing the sustainability of the industry.

More here:
Professor Ross Houston to join BMK Genetics in 2022 - The Fish Site

Entourage Health Enhances Cultivation Platform with Tissue Culture IP and Introduces New Genetics for Premium Adult-Use and Medical Product Lineup in…

Company also confirms its certification as an Ontario Living Wage Employer, becoming one of only three cannabis cultivators with this distinction

TORONTO, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (Entourage or the Company), a Canadian producer and distributor of award-winning cannabis products and brands, announced today it has upgraded its cultivation platform to include a unique Company-wide standardized system rooted in tissue culture propagation that is expected to drive commercial growth for premium products in 2022. In addition to the introduction of new Plant Empowerment practices and new genetics geared at optimal canopy management, the Company is also pleased to confirm it recently received certification as an Ontario Living Wage Employer.

We officially implemented tissue culture propagation across our Strathroy facility to align with our Guelph craft production site and it is now at the heart of Entourages horticultural program - which we fully expect will result in a balanced, consistent canopy that produces higher potency, cannabinoid and terpene-rich cultivars and products, said Patrick Scanlon, Head of Cultivation, Entourage. In our drive to produce the very best for our patients and consumers, we are nurturing and mentoring a world-class cultivation team that together will elevate cannabis products and experiences in Canada. Our balanced approach is already seeing benefits with exciting new genetics for highly sought premium flower products coming in 2022 across all our commercial channels.

Tissue culture propagation is widely recognized as a superior way of growing and preserving agricultural root health and has been primarily used across agricultural channels over the last 60 years. Entourages Guelph facility has developed a proprietary tissue culture program SteadyStem Solutions for the cannabis industry using bio-technology techniques aimed at plant cell growth in a clean, scientific-data driven environment. Its Plant Empowerment approach is a precision agriculture, data-driven philosophy based on environmental monitoring, integrated rootzone management, plant response data and KPIs centered around excellent donor stock that minimizes contamination, promotes genetic integrity and the growth of vigorous, prolific plants.

Story continues

The Company recently regenerated some of its prized cultivars and genetics unique to Entourages brands: Color Cannabis, Saturday Cannabis, Royal City Cannabis Co., and Starseed Medicinal with the goal of meeting evolving consumer preferences for premium products. The full suite of new products is expected to be rolled out starting in early 2022.

Ontario Living Wage Employer Certification

Entourage also announced it has been officially certified as an Ontario Living Wage Employer. A living wage is defined as the income needed for a worker and/or family to meet basic expenses and considers the true costs of living, and participating in their community. It is higher than the provincial minimum wage and draws on community-specific data to determine the rate.

We are proud to be a leader in the living wage movement within the cannabis industry. It is widely proven that businesses like Entourage - who offer a living wage, comprehensive benefits packages, shares programs, merit programs and mentorship opportunities - are more likely to retain and attract talent as well as encourage higher productivity and job satisfaction within their talent pool, said Deborah Sikkema, Chief People Officer, Entourage. Ensuring our workplace is conducive to positive employee engagement is a key measure of success for us, particularly as we look to increase our cultivation and production talent in 2022. We also recognize that a higher standard of living will bring positive change in Ontarios cannabis community as a whole and were thrilled to be at the forefront of this movement.

Visit Entourage Healths newly launched website here. To access our corporate video, visit us here and to access our latest investor presentation and corporate deck here.

About Entourage Health Corp.

Entourage Health Corp. (formerly WeedMD Inc.) is the publicly traded parent company of WeedMD RX Inc. and CannTx Life Sciences Inc., licence holders producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, ON as well as a fully licensed 26,000 sq. ft. Aylmer, ON processing facility, specializing in cannabis extraction. With the addition of Starseed Medicinal, a medical-centric brand, Entourage has expanded its multi-channeled distribution strategy. Starseeds industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with employers and union groups complements Entourages direct sales to medical patients. In October 2021, Entourage closed the acquisition of craft cultivator CannTx Life Sciences Inc. which operates out of its state-of-the-art micropropagation and specialty extraction facility in Guelph, Ontario. Craft brand Royal City Cannabis was added to Entourages elite product portfolio that includes adult-use brands Color Cannabis and Saturday Cannabis sold across eight provincial distribution agencies. The Company also maintains strategic relationships in the seniors market and supply agreements with Shoppers Drug Mart. It is the exclusive Canadian producer and distributor of award-winning U.S.-based wellness brand Marys Medicinals sold in both medical and adult-use channels. Entourage recently announced an exclusive collaboration with The Boston Beer Company subsidiary to launch cannabis-infused beverages in Canada.

For more information, please visit us at http://www.entouragehealthcorp.com

Follow Entourage and its brands on LinkedIn

Twitter: Entourage, Color Cannabis, Saturday Cannabis, Starseed & Royal City Cannabis Co.

Instagram: Entourage, Color Cannabis, Saturday Cannabis, Starseed & Royal City Cannabis Co.

For further information, please contact:

For Investor Enquiries:Valter PintoManaging Director KCSA Strategic Communications1-212-896-1254entourage@kcsa.com

For Media Enquiries:Marianella delaBarreraSVP, Communications & Corporate Affairs416-897-6644marianella@entouragecorp.com

Forward Looking Information This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which are based upon Entourage's current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy. Forward-looking information in this press release includes, but is not limited to, information in respect of the manufacture and distribution of cannabis-infused beverages pursuant to the development, supply, manufacturing, sales and marketing agreements entered into by the Company and the prospects thereof.

The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of Entourage to implement its business strategies; the COVID-19 pandemic; competition; crop failure; and other risks.

Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, Entourage does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for Entourage to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in Entourages disclosure documents filed with the applicable Canadian securities regulatory authorities on SEDAR at http://www.sedar.com. The risk factors and other factors noted in the disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE

Continued here:
Entourage Health Enhances Cultivation Platform with Tissue Culture IP and Introduces New Genetics for Premium Adult-Use and Medical Product Lineup in...

Global Forage Seed Industry Trends, COVID-19 Impact, and Growth Forecast 2021-2026 Featuring Profiles of Leading Players Allied Seed, Brett-Young…

DUBLIN--(BUSINESS WIRE)--The "Forage Seed Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021-2026)" report has been added to ResearchAndMarkets.com's offering.

The global forage seed market is projected to register a CAGR of 7.5%, during the forecast period (2021-2026).

The COVID-19 has led to severe restrictions on the movements of people and goods imposed in the initial months are having widespread negative effects on the industry across the globe with international forage seed trade particularly affected. The forage seed trade is highly international with large volumes of seed shipped across borders to meet farmers' demand across the globe. Yet shipments are affected by lockdowns imposed by governments across the region to stem the Covid-19 pandemic.

Although many governments have since recognized seeds and other agricultural inputs as essential items effectively exempting them from lockdown restrictions seed companies have been reporting a number of supply-chain challenges. However, the market is anticipated to bounce back in the coming months.

The major factors driving the forage seed market are the increasing demand for dairy products, the increasing demand for animal products, consumer preference for organic food and feed products, shrinkage of open land for animal grazing, and increasing specialized feed requirement due to the introduction of high yielding cattle.

Some of the restraints identified in the studied market are adverse climatic conditions, time-based incentive returns requiring significant investments, and the unwillingness of farmers to pay for high-quality forage seeds. The major share in the forage seed market is occupied by North America, followed by Europe, Asia-Pacific, South America, and Africa.

Key Market Trends

Growing Demand for Meat and Meat Products

Livestock is among the world's largest users of land resources, with grazing land and cropland dedicated to the production of feed representing nearly 80% of the total agricultural land. According to FAO, feed crops are grown in 1/3rd of the total cropland, while the total land area occupied by pasture is equivalent to 26% of the ice-free terrestrial surface. Around 80% of the world's grazing lands are open lands, i.e., pastures devoid of forests or dense human settlements. Pastures have always been and will continue to be, a source of forages and nutrients for dairy cattle, including heifers, dry cows, and the milking herd.

Livestock is a major factor responsible for the growth of global agriculture. The world food economy is being increasingly driven by the shift in diet and food consumption patterns toward livestock products. There has been an increased dependency of livestock animals on feed and forage resources. Furthermore, changes in production and quality of feed crop and forages potentially impacts the livestock. The growth in livestock production is likely to create a demand for better forage crops, as people are extremely concerned about the quality of meat they consume. The growth in the demand for forage crops can only be supported with better quality forage seeds.

North America Dominates the Forage Seed Market

Currently, North America is the largest forage seed market. Alfalfa is the largest traded seed among all the categories, and in the United States alone, it accounted for a major share of the market value in 2020. Currently, the United States occupies the largest market share (48%). Favorable weather conditions and an ever-increasing domestic and international demand are driving the growth in the North American forage seed market.

Weather in the North American region is a major reason behind the decline of demand in the forage seed market. To counter this effect, in December 2017, Grassland Oregon, a seed company based in Salem, Oregon, launched FIXatioN Balansa and Frosty Berseem clovers, making them available to producers in Canada. Both varieties are capable of withstanding temperatures as cold as -26C and -5C, respectively.

Competitive Landscape

The global forage seeds market is a fragmented market with the presence of various players in the market. In the forage seed market, AgReliant Genetics, Brett-Young Seeds Limited, Corteva Agri Science, Barenbrug Holding B.V and DLF Seeds A/S are some of the players in the market These players are investing heavily in this market, in order to develop new products.

Key Topics Covered

1 INTRODUCTION

1.1 Study Assumptions & Market Definition

1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.3 Market Restraints

4.4 Porter's Five Forces Analysis

5 MARKET SEGMENTATION

5.1 Crop Type

5.1.1 Cereals

5.1.1.1 Forage Corn

5.1.1.2 Forage Sorghum

5.1.1.3 Other Cereals

5.1.2 Legumes

5.1.2.1 Alfalfa

5.1.2.2 Other Legumes

5.1.3 Grasses

5.2 Product Type

5.2.1 Fresh Forage

5.2.2 Stored Forage

5.2.2.1 Silage

5.2.2.2 Hay

5.3 Geography

5.3.1 North America

5.3.2 Europe

5.3.3 Asia-Pacific

5.3.4 South America

5.3.5 Africa

6 COMPETITIVE LANDSCAPE

6.1 Most Adopted Strategies

6.2 Market Share Analysis

6.3 Company Profiles

6.3.1 Allied Seed LLC

6.3.2 Brett-Young Seeds Limited

6.3.3 AgReliant Genetics

6.3.4 DLF Seeds AmbA

6.3.5 Foster's Seed and Feed

6.3.6 Northstar Seeds Ltd.

6.3.7 Hancock Farm & Seeds Co.

6.3.8 UPL Limited

6.3.9 Corteva Agriscience

6.3.10 The Royal Barenbrug Group

6.3.11 Blue River Hybrid Organic Seeds

6.3.12 AMPAC Seed Company

6.3.13 PGG Wrightson

6.3.14 S&S Seeds, Inc.

6.3.15 Rivard's Turf & Forage

6.3.16 Johnston Seed Company

6.3.17 Silver Falls Seed Company

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

8 IMPACT OF COVID-19 ON THE MARKET

For more information about this report visit https://www.researchandmarkets.com/r/e87l8

More here:
Global Forage Seed Industry Trends, COVID-19 Impact, and Growth Forecast 2021-2026 Featuring Profiles of Leading Players Allied Seed, Brett-Young...

Ohio sheep farmers focus on improved flock genetics at 2021 symposium – Farm and Dairy

WOOSTER, Ohio Isabel Richards, of Gibraltar Farm, in central New York, knows what shes looking for in her sheep herd good body condition, ewes that are good at raising their lambs with minimal help, parasite resistance, to an extent. Not all of the sheep born on her farm make the cut to stay.

But different farms might have different goals for their flocks, Richards said at the 2021 Buckeye Shepherds Symposium, Dec. 3-4, in Wooster, Ohio. She encouraged sheep farmers to focus on whatever traits they want to encourage on their farms.

The big thing is just to see what makes sense for you to select for, she said.

Speakers at the symposium focused on genetics and reproduction. Richards isnt afraid to cull ewes that dont fit her operation.

Our ewe lambs get tough love, she said.

Body condition score is one of the big factors she culls for. There are performance things that she looks for ewes that produce a good number of lambs for their size, ewes that are good at mothering but she also needs them to be able to maintain their body condition scores.

She also selects for growth, to some extent. In New York, hay is expensive. So, Richards tries to raise lambs that can grow to market weight before she has to start feeding hay in the winter.

Mike Stitzlein, who raises club lambs in Ashland, Ohio, considers things like temperament, as well, when he is working on improving his flocks genetics. And as someone who raises lambs for the show ring, hes noticed what the show ring wants isnt always whats best for the sheep industry as a whole.

What pushes club lamb is whats popular in the show ring whats popular in the show ring is just fads, sometimes, Stitzlein said.

But also essential to improving genetics and reproduction is record keeping.

You cant manage what you dont measure, said Brady Campbell, an assistant professor focused on small ruminant management with Ohio State University.

On her farm, Richards tracks things including birth weights, estimated breeding values, mothering ability for ewes, body condition scores, weights at 60 days and 120 days and fecal egg counts for her livestock. The estimated breeding values come from the National Sheep Improvement Program, an organization that offers a system for genetic selection to help sheep farmers improve their herds.

Those things take time, and can be expensive being part of the national program costs Richards about $1,200 per year. But the numbers help her compare how well individual animals, and the herd are doing.

We can measure all day long but we also need to understand that we shouldnt just collect data to collect data, if were not going to use it, Campbell said.

The Ohio Sheep Improvement Association recognized award winners and scholarship recipients at the symposium Dec. 4. The Charles Boyles Master Shepherd Award went to Roger and Jan Cox, of Morrow County.

Roger and Jan Cox raise Katahdin sheep. The Cox family has a long history of sheep farming Rogers father raised sheep, and his ancestors, from Scotland and Ireland, also raised sheep. Roger Cox got his start in sheep with registered Hampshires in 1958, and later shifted to more commercial sheep, getting his first Katahdins in 2005.

Weve been so blessed, Roger Cox said. We had an opportunity to work hard, manage well, and see things come together.

The Distinguished Service Awards went to Gary Wilson, of Jenera; Don Hawk, of Danville; Jordan Beck, of Wauseon; Lori Shroyer, of DeGraff; and Robert Hunter, of Pickerington, all of whom have served on the Ohio Sheep and Wool Program board. Mike Stitzlein, who retired as the president of the association in 2019, received the Presidents Award.

The Friend of the Sheep Industry Award went to Amy Hurst, who assists with keeping track of membership records, checkoff accounting, newsletters and more for the association.

Youth recognized included Rachel Berk and Jim Stickley, with the Ralph H. Grimshaw Memorial Scholarship; Brandon Zuercher, with the Dr. Jack Judy Memorial Scholarship; Chelsea Graham, with the High Family Memorial Scholarship; and Emma Peters, Linsey Eddy and Ian Johnson, with the OSIA LEAD Council Scholarship.

The association also recognized Zoe Parrott, of Northmor FFA, as the state and national FFA sheep production proficiency winner, and Olivia Rinesmith, as the Ohio Lamb and Wool Ambassador.

2021 Buckeye Shepherd's Symposium awards

Representatives of the American Lamb Board gave an update on the checkoff program. Because of the pandemic, said Don Hawk, of the American Lamb Board, the program shifted its strategy to focus less on fine dining, and more on retail and consumer education.

Through partnering with food blogs and getting lamb into new recipes, the program estimates it reached four million or more people in 2020. It is also helping fund several research projects, including one at Michigan State University that looks at the sheep industrys environmental impact.

At the state level, the Ohio Sheep Improvement Association came up with a new strategic plan this year. Three broad goals in the plan are to ensure and maintain effective management, better serve members in Ohio and to provide relevant programming for the Ohio sheep industry.

With strong markets for lamb and wool and a strong base of farmers in the state, the association believes it is well-poised for the future.

We probably have the greatest potential for growth, Hawk said, about the sheep industry east of the Mississippi River.

Up-to-date agriculture news in your inbox!

See more here:
Ohio sheep farmers focus on improved flock genetics at 2021 symposium - Farm and Dairy

The Genetic Lottery is a bust for both genetics and policy – Massive Science

The last decade has seen genetics and evolution grapple with its history; one composed of figures who laid the foundations of their field while also promoting vile racist, sexist, and eugenicist beliefs.

In her new book, The Genetic Lottery, Kathryn Paige Harden, professor of psychology at University of Texas at Austin, attempts the seemingly impossible task of showing that, despite a history of abuse, behavioral genetics is not only scientifically valuable but is an asset to the social justice movement.

In this attempt, she fails twice. For the first half of the book, Harden tries to transform the disappointment of behavioral genetics in the years following the Human Genome Project into a success that proves that genes are a major and important cause of social inequality, like educational attainment or income levels. In the second half, she tries to show that this information is not a justification for inequality, rather it is a tool to use in our efforts to make society more equitable and cannot be ignored if we wish to be successful. To say the least, this section too falls short. Harden refuses to engage with the history and trajectory of her field, and ultimately the science fails to uphold the idea that not considering genetic differences hinders our attempts to create a more equitable world.

In the book Misbehaving Science, sociologist Aaron Panofsky documents the history and progression of behavioral genetics, from its formal inception in the 1960s. Throughout its history behavioral genetics has responded to criticism in a variety of ways.

In 1969, the educational psychologist Arthur Jensen used behavioral genetics methods to argue that IQ gaps between white and Black Americans had genetic origins and, therefore, could not be remedied by educators or social policy. As criticism from mainstream geneticists and evolutionary biologists tied Jensen and behavioral geneticists to each other, the field attempted to hold a middle ground between Jensens racist conclusions and the belief that human behavioral genetics was fundamentally flawed. However, in this attempt to preserve their field from criticism, behavioral geneticists progressively defended the importance of race science research and adopted some core premises about the influence of genetic differences on the racial IQ gap.

In the following decades, Jensen and like-minded researchers like J. Philippe Rushton, Richard Lynn, and Linda Gottfredson received funding from the Pioneer Fund, an organization explicitly dedicated to race betterment. All the while, they were integrated into editorial boards of journals that published behavioral genetics work and treated as colleagues. Even mainstream behavioral genetics work like the Minnesota Study of Twins Reared Apart and the Texas Adoption Project would receive funding from the noxious Fund.

In attempts to justify their field against continued criticism, behavioral geneticists themselves used twin study results to argue social interventions would be ineffective. As Panofsky wrote:

This history, including behavioral genetics' own role in generating, promoting, and defending scientific racism and determinist views of genetics is completely absent from Harden's book. This history matters; it is the source of the isolation of behavioral genetics from mainstream genetics research. This isolation has produced the intellectual and ideologically stagnant lineage that Harden operates in.

These biases are most pronounced in the early chapters walking readers through the science, which often leads to an incomplete, misleading, or mistaken account of genetic research and behavior. Harden presents an argument about the major causal role of genetic differences. These results span decades, including twin studies, and recent developments like genome-wide association studies (GWAS), polygenic scores (a single value combining individual estimated effects of genome-wide variations on a phenotype), and genomic analyses of siblings. Unfortunately, Harden often gives these results in such a misleading way that it obscures how damaging they actually are to her own core thesis.

For example, Harden extols sibling analyses as unassailable evidence of independent, direct genetic causation free of biases found in other methods. While its true that polygenic scores from sibling analyses resolve substantial problems that sometimes create inaccurate associations between DNA and a phenotype, Harden fails to mention several key differences between these sibling-based methods and other genomic or twin-based methods. It is rarely stated clearly that these family methods produce much smaller estimates of genetic effect, often nearly half the size as population-based methods, making the 13% variance explained by current education polygenic scores a likely overestimate. Harden also fails to mention that a commonly used method employed does not fully eliminate the problems from population structure or that estimates from siblings can still include confounding effects that create correlations between genes and environment.

Even worse, Harden moves between the less biased, but smaller, results from sibling methods to the more biased but larger estimates from population-based polygenic scores without being clear this is what she is doing. This happens frequently when discussing research claiming that educational polygenic scores substantially explain differences in income. The result is Harden obscures the fact that more reliable techniques result in lower predicted genetic effects. Readers may be wrongfully led to believe genetic effects are both large and reliable when in reality they are more often one or the other.

Hardens failure to engage with critics of behavioral genetics, often from the political left, veers between simple omissions and outright misrepresentation. This treatment is in stark contrast to how she treats biological determinists on the political right. The work of Charles Murray, the co-author of The Bell Curve, which claimed that differences in IQ scores between the rich and poor were genetic, and whose research aligns neatly with Hardens, is described as mostly true and his political implications are lightly challenged. The most prominent critic of behavioral genetics, Richard Lewontin, gets much rougher treatment.

In one of the three cases in which Harden bothers to mention Lewontins decades-long engagement with behavioral genetics, she gets it wrong, claiming that Lewontin merely said that heritability is useless because it is specific to a particular population at a particular time. In reality, Lewontin showed why the statistical foundation of heritability analyses means it is unable to truly separate genetic and environmental effects. Contra Hardens characterization of her opponents, Lewontin recognized genetic factors as a cause of phenotypes; however, he stressed their effects cannot be independent of environmental factors and the dynamics of development.

Harden implies that giving people access to equal resources increases inequality and genetic influence. Lewontin explained why the outcome of equalizing environments precisely depends on which environment you equalize. As a toy example, a cactus and a rose bush respond differently to varying amounts of water. Giving both plants the same, small, volume of water is good for the cactuss health and bad for the rose, giving both a larger volume of water is bad for the cactus and good for the rose. Equalized environments regardless of quality can reduce or increase inequality and can reduce or increase the impact of genotypic differences depending on the environment and the norm of reaction for a trait and set of genotypes. Heritability analyses cannot provide insight on this distribution or nature of genotype and environment interactions. These detailed, quantitative, and analytic arguments are entirely ignored by Harden.

In her story, people on the political left are ideologically driven to oppose behavioral genetics because they believe it invalidates their desire to ameliorate inequality. In the powerful book-length criticism of behavioral genetics, Not in Our Genes, Lewontin, with neuroscientist Steven Rose and psychologist Leon Kamin, all socialists, defy Hardens characterization of her critics from the left, writing:

They further write:

Not in Our Genes criticizes biological determinism for oversimplifying the processes that create diversity in the natural world. And the ways that biological determinism is employed for political and ideological reasons by people like Arthur Jensen, Daniel Patrick Moynihan, or Hans Eysenck, to undermine movements for social and economic equality on the basis of biological data. Lewontin, Kamin, and Rose did not oppose biological determinism simply on ideological grounds. They knew there was no true threat to egalitarian beliefs posed by biological data if one properly understands biology in a non-determinist way. Instead, they wanted to move beyond just a scientific critique and provide a social analysis of why the mistakes of biological determinism are made, persist, and gain in popularity. They write:

This lack of meaningful engagement with critics is not just poor scholarship, it weakens Hardens case. Problems arise with Hardens discussion of heritability, for example, which would be remedied with a genuine engagement with critics from mainstream genetics and evolutionary biology. Harden takes a hardline position that heritability is a measure of genetic causation within a sampled population; however, despite her attempt over two chapters to build this case, she is still fundamentally mistaken about the concept.

Early work in plant breeding and genetics can help shed light on the source of this confusion. The pre-eminent statistical geneticist, Oscar Kempthorne, in a 1978 critique of behavioral genetics, wrote that the methods employed by the field can tell us nothing about causation because all they really represent is simply a linear association between genetics and phenotypes, without any further ability to connect the two to each other.

The extent to which correlations can be interpreted as causation depends on properly controlling for confounding variables. In the context of heritability, this means that genetics and environment need to be independent of each other, but this cannot be the case without direct experimental manipulation. In fields like plant breeding, it is possible to experimentally randomize which environments a plant genotype experiences, and genetically identical plants can be put in different environments for extra control, so these inferences are safer to make. In human genetics, however, this is not possible even with the sibling and twin methods Harden focuses on. These processes that complicate causal interpretation of heritability estimates have been discussed ad nauseum by other behavioral geneticists, which is why Harden is one of the few who comes to her conclusions.

One final glaring omission worth noting occurs in Hardens chapter on race and findings of behavioral genetics. Here, Harden does an admirable job trying to prevent the misapplication of behavioral genetics to questions of racial differences. Surprisingly absent though is the fact that across a variety of studies, genetic variation is much larger within races compared to between races. This finding undermines core perceptions about the biological nature and significance of race. It also has important implications for our assumptions about the role of genetics in phenotypic differences between races, namely that they will be small to nonexistent. One could speculate the omission is because the finding was from none other than Richard Lewontin. This case is particularly problematic because in randomized control trials, biology classes emphasizing Lewontins findings have shown very strong evidence of reducing racial essentialism, prejudice, and stereotyping. Few science education interventions against racism and prejudice have such strong evidence in their favor.

Above all, Harden desperately wants to impart one idea in the first part of the book: genes cause social inequality. Here she argues for causation as differences makers in counterfactual scenarios. In other words, X causes Y if the probability of Y occurring is different were X not to happen. As Harden notes, experimental science adopts a similar and in ways stronger, interventionist theory of causation, based around experimental interventions. Here X is said to cause Y if there is a regular response of Y to an intervention on X.

Under the interventionist theory, Hardens account of genetic causation runs into trouble. First, it requires us to be able to isolate a specific property on which we can intervene. This is possible in cases of simple genetic disorders with clear biological mechanisms and short pathways from gene to trait, like sickle cell anemia or Tay-Sachs. However, this doesnt work for behaviorally- and culturally-mediated traits involving large numbers of genes, with small effects and diffuse associations between genetic and non-genetic factors. There is simply no method to isolate and intervene on the effects of specific genetic variants that holds environmental factors constant in a way we would normally recognize as an experimental intervention. This applies still to the sibling analyses that Harden tries to portray as randomization experiments. Contrary to one of Hardens more bizarre claims, meiosis does not approximate a randomized experiment. All it does is randomize genotypes with respect to siblings, it does not randomize environments experienced by genotypes. Our broad array of social and cultural institutions still acts in a confounding way. Instead, we just have a polygenic score, which is more a statistical construct than a tangible property in the world.

Second, for Hardens causal claims to hold weight, genetic and environmental factors must be distinct components that are independently disruptable. This reflects what the philosopher John Stuart Mill called the principle of the composition of causes, which states that the joint effect of several causes is identical with the sum of their separate effects. At the core, Harden assumes that genetic and environmental influences on human behavior are independent and separable. To say the absolute least, this is a highly dubious assumption. Based on the arguments from critics like Lewontin and the work from research programs like developmental systems theory, there is very good reason to think that biological systems are not modular, especially in the case of educational attainment. Genetic and environmental influences interact throughout development, the interactions are dynamic, reciprocal, and highly contingent. It simply isnt plausible to estimate the independent effect of one or the other because they directly influence each other.

A further weakness of Hardens book is that just because genes make a difference in phenotype, it does not mean that genes are even relevant to the analysis of these phenotypes. In reality, Lewiss account of causation, that X is a cause if a different outcome would have occurred in the absence of X, can be a pretty low bar, and the causes it identified may not be very relevant. An obviously absurd example is that the argument could be made that the sun caused me to wake up this morning since it is the origin of the trophic cascade that nourished my body enough to continue necessary biological functions. Under Lewis account, the sun is a cause of my waking up, but its hardly a relevant or informative cause compared to my alarm clock or to the bus I need to catch at 8:35am.

In Biology as Ideology, Lewontin discusses the causes of the disease tuberculosis. He notes that in medical textbooks the tubercle bacillus, which gives people the disease when infected, is the cause of tuberculosis. Lewontin writes that this biological explanation is focused on the individual level and treats the biological sphere as independent from external causes related to the environment or social structure. While we can surely talk about the role of the tubercle bacillus in causing the disease we can also talk about the social conditions of unregulated industrial capitalism and its role in causing outbreaks and deaths by tuberculosis and can gain far more insight by analyzing the causes of tuberculosis in that way.

This distinction of whether a cause is relevant for particular social and scientific issues becomes a problem for Harden in the climax of her book where she tries to convince the reader that genetic information is a crucial tool for addressing social inequality.

One example given by Harden is that children who perform well but are in poor schools are able to achieve less, and that poor people with higher education end up making less money than rich people in the same fields. These findings are neither novel nor do they require the use of potentially misleading genetic data. While Harden tries to defuse right-wing arguments about shortcomings of social science research, this isnt a given. As research Harden herself presents shows, results from behavioral genetics bolster the far right and they regularly share this research to promote their beliefs and challenge egalitarian policies. Instead of engaging with this bad-faith criticism from the right, we can simply disregard them, just as Harden disregards their co-option of her field of research.

Finally, Harden expresses a general concern that social science and psychological studies are plagued by genetic confounding, that is the correlations they observe are actually due to unconsidered genetic forces that relate an individual to their outcome (i.e. low income doesnt cause poor health, genes cause both low income and poor health). For this example, Harden is hard on these complaints, equating research that does not include genetic information as tantamount to robbing taxpayers, but light on evidence that this genetic confounding is a widespread problem, or that it can only be addressed with behavioral genetic research.

Surprisingly, all these examples abandon the earlier bluster about genes being crucial causal factors in our life and instead opt for genetic data as one of many methods for causal inference of environmental interventions. We no longer care about heritability estimates; instead, we use twins as an experimental design. In some cases this is fine, however using individuals who have similar genotype, environmental characteristics, and phenotype does not mean that genes are significant causes, its just a good experimental design. Here, some of Hardens arguments about social science research are accurate. Observational and correlation-based studies are weak for a number of reasons, not simply because they ignore genetic differences. The goal should be strengthening causal inference in the social sciences, and we have some idea of how to do that from other fields. To strengthen the ability to identify causes, epidemiologists employ direct experiments, like randomized control trials, exploit natural experiments that can approximate experimental randomization, such as studies that observe changes in outcome shortly after changes in government policy are enacted, or designs that use statistical methods to match people based on background demographic information like income, neighborhood quality, family education, etc.

In fact, there are principled reasons to think genetic data has little to no benefit above and beyond the kinds of data we can collect from non-genetic social science experiments. Eric Turkheimer, Hardens doctoral advisor, has articulated the phenotypic null hypothesis which states that for many behavioral traits the genetic variance identified from behavioral genetics studies is not an independent mechanism of individual differences and instead reflects deeply intertwined developmental processes that are best understood and studied at the level of the phenotype. This certainly appears to hold for the traits Harden talks about. Even with GWAS and polygenic scores, we are given no coherent biological mechanism beyond...something to do with the brain, they interact with and are correlated with the environment, and they are contextual and modifiable. Harden laments focus on mechanisms, but identifying specific causal mechanisms would be precisely how education polygenic scores could be actually helpful. For example, in medicine, GWAS have helped identify potential drug targets by identifying biological mechanisms of disease, and can double the likelihood of a drug making it through clinical trials.

However, this situation doesnt exist for things like education. Instead, we can understand the role of correlated traits like ADHD, or the effect of interventions purely at the phenotypic level by seeing how educational performance and attainment itself change upon interventions from well-designed experiments. In fact, several polygenic scores, from educational attainment to schizophrenia, and even diseases like cardiovascular disease have been shown to have virtually no predictive power beyond common clinical or phenotypic measures, meaning we do not more accurately predict the outcome of those particular phenotypes even with robust polygenic scores. So why not focus our efforts on phenotypes instead of genotypes in cases like education, income, and health where we have some ability to do randomized experiments and a wealth of quasi-natural experiments?

There are existing studies that attempt some kind of true experimental manipulation related to education. Despite what Harden or the charter-school supporting billionaire John Arnold says, we do have some idea on what can improve schools. Research indicates that de-tracking education, that is ending the separation of students by academic ability and having all students engage in challenging curriculum, regularly improves student performance for those with lower ability and does not hinder students with higher ability.

Experiments have shown large benefits to those passing classes and the grades they receive when courses are structured around a more pedagogically informed curriculum that actively engages students. Detracking and active learning have the added advantage of greatly affecting racial gaps in educational performance. To achieve these goals it is likely that teachers will need to be better trained and compensated, and student-pupil ratios would need to change. These changes would likely be related to school funding, teacher salary and quality, and school resources even if those factors are not sufficient to improve educational outcomes in every situation.

Simply identifying that other methods can improve social sciences doesnt mean we shouldnt use every tool in our toolbox, as Harden says. However, there are convincing reasons we ought not to rely on genetic data for this kind of research. One reason is that polygenic scores are not very good as controls for experiments testing the effect of environmental intervention. Research has found that the pervasive interplay of genes and environment weakens their ability to control for genetic confounding or identify the efficacy of environmental interventions. Since polygenic scores can reflect contingent social biases without us knowing, it is possible, and likely, that by relying on them to identify effective interventions we are in fact reifying ingrained social and economic biases further in our systems.

One final concern is how this research is interpreted by people, were it to be widely adopted. Researchers found in online experiments that the very act of classifying someone based on their educational polygenic score led to stigmas and self-fulfilling prophecies. Those with high scores were perceived to have more potential and competence while those with low scores were perceived in the opposite way. Not only does this research suggest genetic data leads to essentialist beliefs that can re-entrench existing inequalities, but this kind of dependency can also create even more confounding influences that complicate the application of genetic data for social science questions.

Finally, we reach the last issue with The Genetic Lottery: we dont need the concept of genetic luck to pursue egalitarian policies. Harden regularly remarks that the alternative is to perceive peoples outcomes as their individual responsibility. Either something is the result of genes they have no control over, or it is their fault for not working hard enough. However, progressive politics revolves around structural and systemic factors that are outside of peoples control and contribute to their outcomes. There is already a recognition of moral luck, or that peoples outcomes are not their fault, but due to the situations they find themselves in. This engagement with progressive motivations and philosophy is absent in Hardens analysis.

In Hardens penultimate chapter she contrasts eugenic, genome-blind, and anti-eugenic approaches to policy. What ultimately occurs is a strawman of genome-blind policy approaches and often anti-eugenic policies that are hard to distinguish from eugenic policies. For example, what is the difference between Hardens description of the eugenic policy Classify people into social roles or positions based on their genetics and the anti-eugenic policy Use genetic data to maximize the real capabilities of people to achieve social roles and positions? While the genome-blind position is described as Pretend that all people have an equal likelihood of achieving all social roles or positions after taking into account their environment., all we really need to do to achieve our progressive goals is ensure that peoples ability to succeed and thrive in life is not conditioned upon their origin, preferences, or abilities. Theres simply no need to use genetic data on people at all.

In another case involving healthcare Harden suggests the genome-blind approach is to keep our system the same while prohibiting the use of genetic information, while the anti-eugenic approach is creating systems where everyone is included, regardless of the outcome of the genetic lottery. However, the system Harden describes is not universal social programs that ensure healthcare, housing, or education regardless of economic situations. Rather it is a system that resembles means-testing social welfare with genetic data. Of course, universal social programs do achieve exactly the anti-eugenic goal while still being genome-blind! Hardens complete disregard for actual rationale and form of progressive policies when crafting the genome-blind caricatures is inexcusable from someone who claims to be progressive.

For a progressive that supports universal healthcare, a living wage for all, housing as a human right, or free education, it does not matter that people are different and it does not matter the cause for that difference. The fact that some people need healthcare to survive is the reason why it should be available for free, whether the need is from an inherited or acquired disease. It is acknowledged that people have different preferences and strengths, which ultimately results in them living different lives. The fact that for some people this means the difference between a living wage and poverty is what progressives take issue with, and it doesnt matter what the cause of these differences are, simply that we address them.

Ultimately, Harden tries to sell us on research that we dont need, based on faulty premises, and that is incapable of delivering on what she promises. Her failure to engage with the history of her own field, her scientific critics, or the actual content of progressive political goals leaves this book in a very poor place. In a way, The Genetic Lottery represents the fact that behavioral genetics no longer has a place to go after the tenets of genetic determinism and biological reductionism were shown to be untenable. If one wants to gain an understanding of modern genetics, or to learn how we may strengthen progressive causes, they should look elsewhere.

Follow this link:
The Genetic Lottery is a bust for both genetics and policy - Massive Science

Genetics pay off as farmers in dry areas report better-than-expected yields – 1430wcmy.com

Many farmers and agronomists are crediting drought tolerant traits for better-than-expected yields in dry regions of the Corn Belt this year.

Pioneer corn product marketing manager Scott Walker tells Brownfield certain genetics really made a difference.

Our AQUAmax products, in 2021 were seeing a 5.8 bushel advantage against competition. And hopefully for the growers thats translating to better-than-expected yields on their farm in more of a challenging growing environment (like) we saw in 21.

He says farmers in Nebraska, Kansas, and Colorado saw record corn yields with many reporting over 300 bushels to the acre.

See the original post:
Genetics pay off as farmers in dry areas report better-than-expected yields - 1430wcmy.com

Animal Genetics Market Worth ($7,705.23 Mn by 2027) by (6.3% CAGR) with Impact of Coronavirus Outbreak and Global Analysis & Forecast by The…

Growth of Animal Genetics Market is attributed to rise in production of porcine and increase in pork consumption across the globe. The same segment is likely to register highest CAGR in the global animal genetics market during the forecast period.

PUNE, India, Nov. 25, 2021 /PRNewswire/ -- According to The Insight Partners study on "Animal Genetics Market to 2027 Global Analysis and Forecast by Animal Genetic Material, Genetic Material and Service" the animal genetics market was valued at US$ 4,778.67 million in 2019 and is projected to reach US$ 7,705.23 million by 2027; it is expected to grow at a CAGR of 6.3% during 20192027. The growth of the market is attributed to the growing preference for animal derived proteins supplements and food products and rising adoption of progressive genetic practices such as artificial insemination (AI) and embryo transfer. However, limited number of skilled professionals in veterinary research and stringent government regulations for animal genetics is expected to hinder the market growth.

The Insight Partners

The North American region holds the largest market share of this market and is expected to grow in forecasted years. The growth in North America is characterized by the presence of new market players, various product launches and increasing government initiatives.

Get Exclusive Sample Pages of Animal Genetics Market - COVID-19 Impact and Global Analysis with Strategic Insights at https://www.theinsightpartners.com/sample/TIPRE00003517/

Likewise, Mexico is likely to offer attractive business opportunities for livestock genetics. Over the last decades, Mexico's beef, pork, and dairy productions have undergone valuable developments. Mexican generators in the expanding livestock intensive systems are frequently using modern genetic improvement technologies such as artificial insemination and embryo transfers.

In North America, the US is the largest market for animal genetics market. Livestock groups provide consumers with different products and services, including meat, milk, eggs, fiber, and draught power. The genetic variation within livestock communities produces the raw material for evolving through natural selection in answer to changing conditions and human-managed genetic improvement plans. As per the Food and Agriculture Organization (FAO), animal genetics is one of the livestock development support. It is a wide field, ranging from characterization to conservation to genetic development. According to the National Institute of Food and Agriculture (NIFA), there have been dramatic improvements in animal production yields and efficiencies. Therefore, the ever-increasing demand for dietary protein in the United States has been observed. These demands are achieved by one the best Animal breeding is one strategy by which these improvements may be performed. NIFA, with the help of scientists from universities and research organizations and food animal industries, provides national leadership and funding opportunities to conduct basic, applied, and integrated research to increase knowledge of animal genetics and genomics.

Story continues

The COVID-19 outbreak has disturbed various trades and businesses across the world. The incidence of corona virus or COVID 19 has not yet been registered the animals. Also, there is no evidence that companion animals are the prime source of the spreading epidemic in humans. However, various studies have been conducted to check the spread of disease from animals to humans. In many cases, zoonotic diseases were found in humans due to interaction with animals. Therefore, government bodies are taking more precautions and safety measures to prevent the spread of corona virus in the animals. The measures are widely carried out for companion animals as they frequently come in contact with their owners. Also, it is essential to report the cases to a veterinary authority. For instance, in the region, to report the cases of detection of COVID-19 is done to OIE through WAHIS, in accordance with the OIE Terrestrial Animal Health Code as an emerging disease.

The OIE is actively working by providing assistance to research for their on-going research and other implications of COVID-19 for animal health and veterinary public health. The assistance is also providing risk assessment, risk management, and risk communication. Also, the OIE has put in place an Incident Coordination System to coordinate these activities. In addition, OIE is also working with the Wildlife Working Group and other partners to develop a long-term work program. The aims are to provide better understandings, dynamics, and risks around wildlife trade and consumption. Also, it aims to develop strategies to reduce the risk of future spillover events.

Download the Latest COVID-19 Analysis on Animal Genetics Market Growth Research Report at https://www.theinsightpartners.com/covid-analysis-sample/TIPRE00003517/

Additionally, various product and service launches have been initiated, which is helping the US market to grow. For instance, The Veterinary Genetics Laboratory (VGL) at the UC Davis School of Veterinary Medicine has launched an updated and advanced website along with several new tests for veterinary community. As the VGL is one of the foremost genetic testing laboratories in the world, the new site and tests will bring yet another level of global impact to the top-ranked veterinary school. Thus, the consistent support for combating addiction in the country undertaken by various organizations likely to augment the growth of animal genetics market during the forecast years.

The Asia Pacific region is expected to be the fastest-growing region among all other regions. The growth of the market in the region is majorly due to countries like China, India and Japan, which drives the major consumption of animal derived products. Moreover, growing preference for animal derived proteins supplements and food products, and rising adoption of progressive genetic practices such as artificial insemination (AI) and embryo transfer are also likely to contribute to market growth. On the other hand, significant investment by government in various breeding programs is supporting the growth of market. For instance, the central and local governments have invested more than RMB 5 billion to build breeding or multiplier farms and conservation farms for breed improvement programs and the building of centers for testing the quality of breeding stock, semen, and embryos.

Based on product, the animal genetics market is segmented poultry, porcine, bovine, canine, and others. The porcine segment accounted for more than 35.84% of the market share in 2019. In terms of genetic material, the animal genetics market is segmented into semen, and embryo. The embryo segment held the largest share of the market in 2019. In terms of service, the animal genetics market is segmented into DNA typing, genetic trait tests, genetic disease tests, and others.The DNA typing segment held the largest share of the market in 2019.

Rising Adoption of Progressive Genetic Practices Such as Artificial Insemination (AI) and Embryo Transfer in Animal Genetics Market:

Growing focus on developing superior animal breeds using genetic engineering to obtain high reproduction rates for large-scale production of modified breeds is expected to drive animal genetics market during the forecast period. Animal genetics emphasizes the inheritance and genetic variations in wild and domestic animals. This science is used at a commercial level for services such as testing genetic disorders, screening genetic traits, and typing DNA. For identifying genetic hybridizations, animal genetics uses various genetic practices, such as artificial insemination, embryo transfer, and cytological studies. Moreover, artificial insemination (AI) can reduce various risks involved in animal breeding and disease transmission. It is found that female offspring cattle born through artificial insemination yield more milk than normal offspring. Additionally, the use of antibiotic-containing semen extensors is effective in preventing bacterial infectious diseases. Therefore, the entire AI process is considered hygienic than natural mating.

The market players are focusing on partnerships, collaboration, and acquisitions to develop genetically modified breeds and maintain their market share. For instance, in August 2020, Cogent and AB Europe collaborated to launch a novel sexed semen service for sheep producers in the UK. In May 2018, Recombinetics entered into partnership agreement with SEMEX for the implementation of a precision breeding program, which is expected to improve animal health and well-being through hornless dairy cattle genetics. According to the Brazilian Association of Artificial Insemination, the number of commercialized doses of semen increased from 7 million in 2003 to ~14 million in 2017. Thus, rising adoption of genetic practices will support the market growth in coming years.

Inquire before Buying (Animal Genetics Market Research): https://www.theinsightpartners.com/inquiry/TIPRE00003517/

Market: Segmental Overview

In terms of product, porcine segment is anticipated to register the highest CAGR during the forecast period. Growing production of porcine and increase in pork consumption is likely to favor the growth of the market. Pork is the most consumed meat across the globe. In the US, pork production generates $23.4 billion output per year. Additionally, 26% that is around 2.2 million metric tons of pork and its products are exported to other countries. Despite of the challenges such as tariffs, labor and disease risks, the pork industry in US is still growing with around 66,000 sows in 2019. Also, developments by the major pork producers in the country is likely to grow the pork production industry. For instance, in 2017, 123-year-old Clemens Food Group partnered with 12 independent hog farmers to establish a new packing plant in Michigan. Thus, growing pork production industry is likely to favor market growth. In terms of genetic material, the animal genetics market is segmented into semen, and embryo. The embryo segment held the largest share of the market in 2019. In terms of service, the animal genetics market is segmented into DNA typing, genetic trait tests, genetic disease tests, and others.The DNA typing segment held the largest share of the market in 2019.

Animal Genetics Market: Competition Landscape and Key Developments

Neogen Corporation, Genus, Groupe Grimaud, Topigs Norsvin, Zoetis Services Llc, Hendrix Genetics Bv, Envigo, Vetgen, Animal Genetics Inc, Alta Genetics Inc. and among others are among the key companies operating in the animal genetics market. These players are focusing on the expansion and diversification of their market presence and the acquisition of a new customer base, thereby tapping prevailing business opportunities.

Order a Copy of Animal Genetics Market Shares, Strategies and Forecasts 2021-2028 Research Report at https://www.theinsightpartners.com/buy/TIPRE00003517/

In September 2020, Genus Plc and Tropic Bioscience entered into collaboration. Tropic Biosciences the pioneering agricultural-biotechnology company entered into collaboration with Genus in order to explore the application of Tropic's Gene Editing induced Gene Silencing (GEiGS) technology in porcine and bovine genetics.

In July 2020, Topigs Norsvin entered into strategic partnership with Acuity swine genetics company. This partnership will provide the opportunity for joint collaboration and expansion of technical expertise, commercial product testing and supply chain infrastructure in animal genetics market across the North America region.

In April 2020, Zoetis Animal Genetics and Angus Australia have entered into a strategic partnership that will aid Australian Angus breed stock and commercial breeders an additional benefit from genomic, or DNA-based technology. Zoetis have made a considerable investment in the expansion of the Angus genomic reference population through the provision of genotyping services and sponsorship.

Browse Related Reports and Get Sample copy

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer JoshiE-mail: sales@theinsightpartners.com Phone: +1-646-491-9876Press Release: https://www.theinsightpartners.com/pr/animal-genetics-market More Research: https://www.einpresswire.com/newsroom/the_insight_partners/

Cision

View original content:https://www.prnewswire.com/news-releases/animal-genetics-market-worth-7-705-23-mn-by-2027-by-6-3-cagr-with-impact-of-coronavirus-outbreak-and-global-analysis--forecast-by-the-insight-partners-301432104.html

SOURCE The Insight Partners

Read this article:
Animal Genetics Market Worth ($7,705.23 Mn by 2027) by (6.3% CAGR) with Impact of Coronavirus Outbreak and Global Analysis & Forecast by The...

Learn about your genetics for just $100 with this Cyber Monday 23andMe deal – Livescience.com

With this Cyber Monday 23AndMe deal, you can make a great saving as you delve into your ancestry. Have you ever wondered what parts of the world your family is from? What about what your DNA might tell you about which health issues you may be predisposed to? Well wonder no more, as this deal from Amazon gives 50% off the Health + Ancestry service a savings of $100 over its normal price.

23andMe created the first direct-to-consumer autosomal genetic testing product over a decade ago, and its testing on both ancestry and health is still one of the top options on the market right now. With the Health + Ancestry kit, you register your product, collect saliva, and send it back to the company for them to analyze.

Six to eight weeks later, you're given access to a range of results about your genetic ancestors. In your Ancestry Composition Report, youre shown how much of your DNA overlaps with 45 different worldwide genetic populations. Going way back, the report also shows you how much you may descend from Neanderthals, the group that interbred with homo sapiens potentially as recently as 47,000 years ago. The company also compares your DNA to that of people in over 150 countries, which may indicate where your more recent ancestors lived. For more discounts like this, head over to our Cyber Monday Ancestry DNA kit deals.

There is also the chance to opt-in to a service called DNA Relatives. This feature allows you to search for genetic members of your family and check which parts of your DNA overlap with theirs. You can search for relatives on either side of your family tree with this feature.

While there is a kit with just ancestry information alone, also on sale for 50% off today for Cyber Monday at Amazon, this package also includes health information such as carrier status and risk for certain conditions. For carrier status, the test checks to see whether you carry certain genes for conditions that can be passed down to your children, even though you may not have that particular health issue yourself. This 23andMe product also includes a Health Predisposition Report. This tells you whether you have a genetic variant that the company has associated with a higher risk of developing a disease such as Parkinsons or Alzheimers.

While some parts of the health testing in this kit have now been approved by the FDA, 23andMe notes that this analysis does not diagnose you and does not intend [to] tell you anything about your risk for developing a disease in the future. (Check out our 2018 article on what to know before taking 23andMes breast cancer test.) They also note that you should not change anything about your treatment for a disease based on this information, such as starting or stopping a medication. If you have any concerns about carrying a condition or your risk of developing a health issue, you should consult your doctor for medical advice.

With that being said, this test may be an interesting way to compare your genes to others, as the report also gives you information about wellness issues your genes may affect, such as how your body digests alcohol, caffeine, or lactose. The test also tells you if you are predisposed to certain traits like curly or wavy hair, or how you may perceive certain foods.

For more great savings, head over to our Cyber Monday binoculars deals.

Read this article:
Learn about your genetics for just $100 with this Cyber Monday 23andMe deal - Livescience.com

Webinars to focus on genetic conditions – The County

AdobeStock_127678511

(AdobeStock)

(AdobeStock)

Cary Medical Center, in partnership with The New England Regional Genetic Network, is teaming up with the Weitzman Institute to inspire primary care innovation in the screening and treatment of patients with genetic conditions.

CARIBOU, Maine Cary Medical Center, in partnership with The New England Regional Genetic Network, is teaming up with the Weitzman Institute to inspire primary care innovation in the screening and treatment of patients with genetic conditions.

Cary Medical Center received a grant from NERGN to help educate and connect underserved populations with resources and support related to genetic conditions, said Angel Murchison, grant outreach coordinator for the genetics program.

To better serve these communities, we are also promoting educational opportunities for primary care providers.

The NERGN Genetics webinar series will be offered by the Weitzman Institute, which aims to improve access to genetics services for underserved populations by offering primary care providers educational support through free webinars that enhance provider knowledge, practice, and attitudes regarding genetic services.

This series will also provide perspectives from other providers and participants in the New England area.

Webinar dates, times and topics are as follows.

Tuesday, Dec. 14, 12-1 p.m.: genetics referrals.

Tuesday, Jan. 11,12-1 p.m.: financial aspects of genetic testing.

Tuesday, Feb. 8, 12-1 p.m., newborn screening and genetic therapies.

Tuesday, March 8, 12-1 p.m., school-aged patients and considerations.

To register for one or all of these free seminars, visit chc1.zoom.us/webinar/register/WNUUKAgqr5QUGpb8caMKLgAg. Continuing education credits will be given for attending the live event.

Genetic webinars, as well as genetics-related ECHO sessions, will be archived on NERGNs website https://www.negenetics.org/professionals.

For more information visit http://www.negenetics.org.

Thank you for reading your 4 free articles this month. To continue reading, and support local, rural journalism, please subscribe.

The rest is here:
Webinars to focus on genetic conditions - The County

Genetic Testing Services Market is Anticipated to Reach a Value of US$ 64.1Billion By the End of 2025 – BioSpace

Genetic Testing Services Market- Usage of Healthcare IT Provides Ample Expansion Opportunities, Finds Fact.MR

Fact.MRs latest report on Genetic Testing Services Market offers unbiased industry analysis for the period between 2020 and 2025. The study divulges exclusive information about existing opportunities and emerging trends across leading segments in terms of product, usage and end user. It also highlights various strategies employed by key manufacturers to gain edge in the market.

Fact.MR A Market Research and Competitive Intelligence Provider: According to the latest Fact.MR analysis, the global genetic testing services market size would reach US$ 64,131.4 million by 2025 and is expected to grow at a healthy CAGR of 7.6% between 2020 and 2025.

Genetic testing services have found widespread applications in several healthcare fields. These include oncology, obstetrics and ancestry. Genetic testing is predominantly used in determining the prevalence of various autoimmune diseases like rheumatoid arthritis, Type-1 diabetes mellitus, multiple sclerosis, cancers and Guillain-Barre syndrome.

On the back of these factors, the global genetic testing services market is set to burgeon in the future. The market is set to record robust expansion with a CAGR of 7.6% during the forecast period (2020-2025), surpassing a value of US$ 64,131.4 Mn by 2025. Increase in the number of geriatric patients and spread of communicable and non-communicable diseases are also anticipated to leverage the genetic testing services market.

Want A Detailed Understanding of Market Functioning? Request for a Sample Here

https://www.factmr.com/connectus/sample?flag=S&rep_id=4744

Key Takeaways of Global Genetic Testing Services Market:

By test-type, new born screening is set to expand rapidly during the forecast period, recording a CAGR of 8.4%. Increasing incidences of hyperthyroidism and other chronic diseases among infants is projected to boost this segment.

Hospital-based laboratories are set to gain maximum traction in the global genetic testing services market during the forecast period. This is attributed to the rising prevalence of hospitalization within the geriatric population who suffer from a number of ailments. The segment is anticipated to account for two-fifth of the overall genetic testing services market.

The oncology segment shall find maximum application for genetic testing services in the future. The segment shall register an impressive CAGR of 8% during the forecast period. Rising cases of cancer and increased awareness about early diagnosis is expected to drive the segments growth.

Autoimmune diseases segment shall gain significant traction, owing to importance of tracing hereditary-based factors responsible for the prevalence of diseases like cancers. The segment is projected to expand at a CAGR of 7.8%.

North America shall dominate the global genetic testing services market, owing to increased demand for knowing ancestry, in-vitro fertilization and pre-implantation testing. The region shall hold around two-fifth of the global genetic testing services market, registering a robust CAGR of 7% in the forecast period.

Asia-Pacific projects lucrative possibilities for the expansion of the global genetic testing services market. Rising prevalence of cancer and increased incidences of genetic disorders such as Huntingtons disease are expected to boost market share in the region. A robust CAGR of 8.4% is predicted for the region.

The COVID-19 pandemic is anticipated to stimulate the growth of the genetic testing services market. As hospitals are reaching a saturation point, key companies are investing in various genetic testing methods to assist healthcare professionals in diagnosing and treating COVID-19.

Recently, Avellino Lab USA announced additional production shifts to scale up the manufacturing of the SARS-CoV-2/COVID-19 Test. Christened AvellinoCoV2, this ultra-rapid genetic test helps clinicians diagnose COVID-19 by identifying and isolating the genetic markers as approved by the FDA and the CDC. It is highly reliable and accurate as well.

Likewise, MedGenome and SciGenom Research Foundation have published research into genetic susceptibility of the COVID-19 disease. The research concludes that there are variants in the ACE-2 gene that will help protect individuals from infection. The firms hope to eventually develop a potential drug based on these variants in collaboration with a suitable pharmaceutical company.

The global genetic testing services market shows prolific growth opportunities in the future. With increased prevalence of autoimmune diseases, patients are increasingly seeking solutions that help them determine hereditary anomalies and seek appropriate treatment. This is expected to majorly boost the market, concludes a Fact.MR analyst.

Get Customization on this Report for Specific Research Solutions-

https://www.factmr.com/connectus/sample?flag=RC&rep_id=4744

Global Genetic Testing Services: Competition Landscape

The global genetic testing services market consists of the following players: Laboratory Corporation of America Holdings, Quest Genetics Incorporated, Genomic Health, Inc., NeoGenomics Laboratories, Inc., Eurofins Scientific, Ambry Genetics and 23andMe, Inc. Laboratory Corporation of America Holdings dominates the genetic testing services market. It provides specialty testing services in womens health, Genetic genetics, allergies, cardiovascular disease and cancer Genetics.

The company processes tests on more than 3 million patient specimens per week and serves hundreds of thousands of customers in the United States. Likewise, Quest Genetics Incorporated offers various Genetic and clinical tests for several medical conditions such as hepatitis C, arthritis, cardiovascular diseases, neurology, Genetics, Pediatrics, autoimmune diseases and cancers. The companys main area of expertise is in providing Genetic information services.

Looking for more information?

The research study on the global genetic testing services market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global Genetic testing services market over 2020-2025. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2025. Market statistics have been presented on the basis of Test Types (Prenatal Testing, New Born Screening, Predictive and Presymptomatic Testing, Pharmacogenomic Testing & Others) Service Providers (Hospital-based Laboratories, Genetic Laboratories, Specialty Clinics and Others) & Applications (Oncology, Infectious Diseases, Autoimmune Diseases and Others) across five major regions.

Key Questions Answered in Fact.MR Genetic Testing Services Market Report

Which regions will continue to remain the most profitable regional markets for Genetic Testing Services market players?

Which factors will induce a change in the demand for pleural catheter manufacturers during the assessment period?

How will changing trends impact the Genetic Testing Services market?

How can market players capture the low-hanging opportunities in the Genetic Testing Services market in developed regions?

Which companies are leading the Genetic Testing Services market?

What are the winning strategies of stakeholders in the Genetic Testing Services market to upscale their position in this landscape?

Important Insights Enclosed in the Report:

Technological developments within the Genetic Testing Services market sphere

Growth prospects for new market players across different regions

Company profiles of leading players in the Genetic Testing Services market

Up-to-date insights related to the key success factors impacting the growth of the Genetic Testing Services market

Recent mergers, acquisitions, partnerships, and strategic alliances

To gain in-depth insights on Genetic Testing Services Market, request methodology at

https://www.factmr.com/connectus/sample?flag=RM&rep_id=4744

Global Genetic Testing Services Market Segmentation

Fact.MR has studied the global genetic testing services market with detailed segmentation on the basis of test types, service providers, applications and key regions.

Test types

Service providers

Applications

Key Regions

Explore Fact.MRs Coverage on the Healthcare Domain

Preimplantation Genetic Testing Market - Preimplantation Genetic Testing Market Forecast, Trend Analysis & Competition Tracking Global Market insights 2021 to 2031

Genetic Disorder Therapeutics Market Analysis- Genetic Disorder Therapeutics Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2026

Animal Genetics Market Forecast- Animal Genetics Market Research Report Segmented By Product (Live Animals, Genetic Material, Genetic Testing), By Live Animals (Bovine, Porcine, Poultry, Canine, Piscine, Others), By Genetic Material (Semen, Embryo, Others), & By Region - Global Market Insights 2020 to 2026

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range from automotive & industry 4.0 to healthcare, technology to even the most niche categories. 80% of Fortune 1000's trust us in critical decision making.

MarketNgage is powered by Fact.MR our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.

You can access all our healthcare research reports by signing up with MarketNgages Market Research Subscription with FREE credits. MarketNgage is powered by Fact.MR A Fully integrated research solution for seamless single-window access Widest coverage on emerging markets, nascent products, and disruptive technologies.

Contact:

Mahendra SinghUS Sales Office11140 Rockville PikeSuite 400Rockville, MD 20852United StatesTel: +1 (628) 251-1583E: sales@factmr.com

Source: Fact.MR

See the original post here:
Genetic Testing Services Market is Anticipated to Reach a Value of US$ 64.1Billion By the End of 2025 - BioSpace